Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study
Aging2015Vol. 7(12), pp. 1066–1074
Citations Over TimeTop 22% of 2015 papers
Claire Falandry, Béatrice Horard, Amandine Bruyas, Éric Legouffe, Jacques Cretin, Jérôme Meunier, Jérôme Alexandre, Valérie Delecroix, Michel Fabbro, Marie-Noëlle Certain, Raymonde Maraval-Gaget, Éric Pujade-Lauraine, Éric Gilson, Gilles Freyer
Abstract
This exploratory study identifies TL as predictive factor of decreased treatment completion, SAE risk, unplanned hospital admissions and OS after adjustment on FIGO stage.
Related Papers
- → Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics(2005)165 cited
- → TRF1 is a critical trans-acting factor required for de novo telomere formation in human cells(2000)35 cited
- → Telomeres as dynamic structures of human genome: the effect of endogenous and exogenous factors(2022)3 cited
- → Molecular Manifestations and Molecular Determinants of Telomere Capping(2000)68 cited
- [Relationship between telomere length and clinical and biological characteristics of the cancers with telomerase reactivation].(1998)